Loading patent…
OwnerSamuel J. Hassenbusch, Mary Jane Johansen +3inventors
InventorsSamuel J. Hassenbusch, Mary Jane Johansen, Tamara Lee Gradert, William C. Satterfield, Larry Trissel
Estimating the term…
The invention provides a preservative-free midazolam hydrochloride formulation that is less toxic, and more effective than present opioid therapies for alleviation of pain. Additionally, by an intrathecal infusion system for continuous administration of preservative-free midazolam hydrochloride the present invention circumvents breakthrough pain episodes often encountered with other means of opioid administration. The present invention further provides a novel method of treating pain that is of either non-neuropathic or neuropathic origin. Overall that present invention provides a method of treating cancer pain in patients by continuous intrathecal infusion of preservative-free midazolam hydrochloride.
A method for treating pain in a subject comprising intraspinal administration to said subject of an analgesic formulation comprising preservative-free midazolam, wherein said formulation is substantially free of other analgesic substances.
Dependencies are inferred from the claim text.